Browse by UCL Departments and Centres
![]() | Up a level |
Group by: Author | Type
Number of items: 16.
C
| Camp, SJ and Thompson, AJ and Langdon, DW (2001) A new test of memory for multiple sclerosis I: Format development and stimuli design. MULT SCLER , 7 (4) 255 - 262. |
F
| Freeman, JA and Hobart, JC and Thompson, AJ (2001) Does adding MS-specific items to a generic measure (the SF-36) improve measurement? NEUROLOGY , 57 (1) 68 - 74. |
| Freeman, JA and Thompson, AJ and Fitzpatrick, R and Hutchinson, M and Miltenburger, C and Beckmann, K and Dahlke, F and Kappos, L and Polman, C and Pozzilli, C and European Study Grp Interferon-Beta1b, (2001) Interferon-beta 1b in the treatment of secondary progressive MS - Impact on quality of life. NEUROLOGY , 57 (10) 1870 - 1875. |
| Freeman, JA and Thompson, AJ and Freeman, JA (2001) Building an evidence base for multiple sclerosis management: support for physiotherapy. J NEUROL NEUROSUR PS , 70 (2) 147 - 148. |
H
| Hobart, JC and Thompson, AJ (2001) The five item Barthel index. J NEUROL NEUROSUR PS , 71 (2) 225 - 230. |
| Hobart, J and Freeman, J and Lamping, D and Fitzpatrick, R and Thompson, A (2001) The SF-36 in multiple sclerosis: why basic assumptions must be tested. J NEUROL NEUROSUR PS , 71 (3) 363 - 370. |
| Hobart, J and Lamping, D and Fitzpatrick, R and Riazi, A and Thompson, A (2001) The Multiple Sclerosis Impact Scale (MSIS-29) - A new patient-based outcome measure. BRAIN , 124 962 - 973. |
| Hobart, JC and Thompson, AJ (2001) Assessment measures and clinical scales. In: Guiloff, RJ, (ed.) Clinical trials in neurology. (17 - 28). Springer Verlag: London. |
J
| Jarrett, L and Leary, SM and Porter, B and Richardson, D and Rosso, T and Powell, M and Thompson, AJ (2001) Managing spasticity in people with multiple sclerosis: a goal-oriented approach to intrathecal baclofen therapy. International Journal of MS Care , 3 (4) |
K
| Kappos, L and Polman, C and Pozzilli, C and Thompson, A and Beckmann, K and Dahlke, F and European Study Grp Beta-1b Seconda, (2001) Final analysis of the European multicenter trial on IFN beta-1b in secondary-progressive MS. NEUROLOGY , 57 (11) 1969 - 1975. |
M
| McDonald, WI and Compston, A and Edan, G and Goodkin, D and Hartung, HP and Lublin, FD and McFarland, HF and Paty, DW and Polman, CH and Reingold, SC and Sandberg-Wollheim, M and Sibley, W and Thompson, AJ and van den Noort, S and Weinshenker, BY and Wolinsky, JS (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. ANN NEUROL , 50 (1) 121 - 127. |
P
| Polman, CH and Thompson, AJ and Murray, TJ and McDonald, WI (2001) Multiple sclerosis: the guide to treatment and management. (5th ed.). Demos: New York. |
T
| Thompson, AJ (2001) Symptomatic management and rehabilitation in multiple sclerosis. J NEUROL NEUROSUR PS , 71 II22 - II27. |
| Thompson, AJ (2001) Drug treatment of neurological disability. In: Edwards, S, (ed.) Neurological physiotherapy: a problem solving approach. (155 - 168). Churchill Livingstone: London. |
| Thompson, AJ (2001) Symptomotic treatment and rehabilitation. In: Polman, CH and Thompson, AJ and Murray, TJ and McDonald, WI, (eds.) Multiple sclerosis: the guide to treatment and management. (43 - 78). Demos: New York. |
W
| Willison, HJ and O'Leary, CP and Veitch, J and Blumhardt, LD and Busby, M and Donaghy, M and Fuhr, P and Ford, H and Hahn, A and Renaud, S and Katifi, HA and Ponsford, S and Reuber, M and Steck, A and Sutton, I and Schady, W and Thomas, PK and Thompson, AJ and Vallat, JM and Winer, J (2001) The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. BRAIN , 124 1968 - 1977. |


